Literature DB >> 26667371

Anterior Cruciate Ligament Injuries in Professional Hockey Players.

Robby Sikka1, Chad Kurtenbach2, J Tyler Steubs2, Joel L Boyd2, Bradley J Nelson2.   

Abstract

BACKGROUND: Performance outcomes and return-to-play data have been reported after anterior cruciate ligament (ACL) injuries in professional football and basketball, but they have rarely been reported in professional hockey. HYPOTHESIS: The hypothesis was that performance after ACL reconstruction would be comparable to prior levels of play in a series of National Hockey League (NHL) players. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: The NHL Injury Surveillance System (ISS) was utilized to identify all players with an ACL injury between 2006 and 2010. Medical staff members for all NHL teams were surveyed regarding these injuries. The medical staff completed a questionnaire for each injury, and statistics were analyzed using multiple analyses of variance to compare outcomes, performance, and the complication rate. A control group was identified and matched based on performance, career length before injury, age, height, and weight.
RESULTS: There were 47 players identified by the NHL ISS. There were 3 goalies, 8 defensemen, and 36 wings or centers. The average age of these players was 27.69 years. The average length of time played after the injury was 2.8 years, which was less than that of the control group (4.4 years) (P = .004). The presence of a meniscal injury was associated with a decreased length of career compared with the control group (P = .012) and with patients with an isolated ACL injury (P = .002). For wings and centers, the number of games played decreased from 71.2 to 58.2 in the first full season after the injury (P = .05) and to 59.29 in the second season (P = .03). In the first season after the injury, for forwards and wings, assists and total points decreased from 20.3 and 35.2 to 13.8 (P = .005) and 25.9 (P = .018), respectively. In the second season after the injury, assists and goals decreased to 10.0 (P = .002) and 10.0 (P = .013), respectively. Compared with controls, the per-season averages of goals (P = .001), assists (P = .010), and total points (P = .004) decreased. Four players (8.5%) had subsequent failure of reconstruction, and there was a total reoperation rate of 20%. Five players (10.6%) did not return to play, and 4 (8.5%) were unable to return to play for a full season.
CONCLUSION: Most players are able to return to play in the NHL after an ACL injury. However, career length and performance may be significantly decreased compared with controls. This may represent a more severe initial injury, and more focused return-to-play pathways may identify barriers to return to play.
© 2015 The Author(s).

Entities:  

Keywords:  anterior cruciate ligament; hockey; knee; ligament; sports

Mesh:

Year:  2015        PMID: 26667371     DOI: 10.1177/0363546515616802

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  12 in total

1.  Concussion and National Hockey League Player Performance: An Advanced Hockey Metrics Analysis.

Authors:  Thomas A Buckley; Kelsey N Bryk; Kathryn L Van Pelt; Steven P Broglio; Stephen A East; Scott L Zuckerman; Andrew W Kuhn
Journal:  J Athl Train       Date:  2019-04-01       Impact factor: 2.860

Review 2.  On-Ice Return-to-Hockey Progression After Anterior Cruciate Ligament Reconstruction.

Authors:  Jacob J Capin; William Behrns; Karen Thatcher; Amelia Arundale; Angela Hutchinson Smith; Lynn Snyder-Mackler
Journal:  J Orthop Sports Phys Ther       Date:  2017-03-29       Impact factor: 4.751

3.  High revision arthroscopy rate after ACL reconstruction in men's professional team sports.

Authors:  Hendrik Bloch; Claus Reinsberger; Christian Klein; Patrick Luig; Werner Krutsch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-08-17       Impact factor: 4.114

4.  Impact of surgical timing on the outcome of anterior cruciate ligament reconstruction.

Authors:  Elmar Herbst; Christian Hoser; Peter Gföller; Caroline Hepperger; Elisabeth Abermann; Katharina Neumayer; Volker Musahl; Christian Fink
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-08-22       Impact factor: 4.342

Review 5.  Epidemiology of Injuries in Ice Hockey.

Authors:  Gregory R Anderson; Heath P Melugin; Michael J Stuart
Journal:  Sports Health       Date:  2019-06-03       Impact factor: 3.843

6.  Return to Sport Composite Test After Anterior Cruciate Ligament Reconstruction (K-STARTS): Factors Affecting Return to Sport Test Score in a Retrospective Analysis of 676 Patients.

Authors:  Florent Franck; Adnan Saithna; Thais Dutra Vieira; Charles Pioger; Gregory Vigne; Meven Le Guen; Isabelle Rogowski; Jean-Marie Fayard; Mathieu Thaunat; Bertrand Sonnery-Cottet
Journal:  Sports Health       Date:  2021-02-06       Impact factor: 3.843

7.  Return to Play After Patellar Tendon Autograft for Primary Anterior Cruciate Ligament Reconstruction in Rugby Players.

Authors:  Eoghan T Hurley; Dan Withers; Enda King; Andrew Franklyn-Miller; Mark Jackson; Ray Moran
Journal:  Orthop J Sports Med       Date:  2021-05-03

8.  Return to Sport and Performance After Anterior Cruciate Ligament Reconstruction in National Football League Linemen.

Authors:  Mark E Cinque; Charles P Hannon; Daniel D Bohl; Brandon J Erickson; Nikhil N Verma; Brian J Cole; Bernard R Bach
Journal:  Orthop J Sports Med       Date:  2017-06-20

9.  National Football League Skilled and Unskilled Positions Vary in Opportunity and Yield in Return to Play After an Anterior Cruciate Ligament Injury.

Authors:  JaeWon Yang; Jonathan D Hodax; Jason T Machan; Eric S Secrist; Wesley M Durand; Brett D Owens; Adam E M Eltorai; Christopher C Dodson
Journal:  Orthop J Sports Med       Date:  2017-09-21

10.  Return to Play After Multiligament Knee Injuries in National Football League Athletes.

Authors:  Neil K Bakshi; Moin Khan; Simon Lee; Fred T Finney; Jeff Stotts; Robby S Sikka; Asheesh Bedi
Journal:  Sports Health       Date:  2018-04-11       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.